Literature DB >> 12228032

Long Bone Osteomyelitis.

Luca Lazzarini1, Fausto De Lalla, Jon T. Mader.   

Abstract

Osteomyelitis is a complex disease that is often associated with high morbidity and considerable health care costs. Bacteremia, contiguous focuses of infection, penetrating trauma, or surgery are the major predisposing factors for this infection. Bone necrosis and bone destruction occur early in the course of osteomyelitis, leading to a chronic process and eliminating the host's ability to eradicate the pathogens. The presence of poorly vascularized tissues, the adherence to bone structures and implants, and a slow bacterial replication rate are recognized as important factors for the persistence of the infection. Treatment of osteomyelitis is particularly challenging and involves adequate antimicrobial therapy and surgical debridement of all necrotic bone and soft tissues. Antibiotic treatment is usually started on an empiric basis and then modified according to the results of cultures and sensitivity tests. Surgical treatment consists of debridement, obliteration of dead space, adequate soft tissue coverage, restoration of blood supply, and stabilization.

Entities:  

Year:  2002        PMID: 12228032     DOI: 10.1007/s11908-002-0012-4

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  49 in total

1.  Postoperative Mycobacterium avium osteomyelitis confirmed by polymerase chain reaction.

Authors:  J A Weigl; W H Haas
Journal:  Eur J Pediatr       Date:  2000 Jan-Feb       Impact factor: 3.183

Review 2.  Epidemiology in bone and joint infection.

Authors:  W J Gillespie
Journal:  Infect Dis Clin North Am       Date:  1990-09       Impact factor: 5.982

3.  Collagen and fibronectin binding in experimental staphylococcal osteomyelitis.

Authors:  A Johansson; J I Flock; O Svensson
Journal:  Clin Orthop Relat Res       Date:  2001-01       Impact factor: 4.176

4.  Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions.

Authors:  G E Friedlaender; C R Perry; J D Cole; S D Cook; G Cierny; G F Muschler; G A Zych; J H Calhoun; A J LaForte; S Yin
Journal:  J Bone Joint Surg Am       Date:  2001       Impact factor: 5.284

5.  Clindamycin in the treatment of osteomyelitis in children: a report of 29 cases.

Authors:  W Rodriguez; S Ross; W Khan; D McKay; P Moskowitz
Journal:  Am J Dis Child       Date:  1977-10

6.  Detection of prosthetic hip infection at revision arthroplasty by immunofluorescence microscopy and PCR amplification of the bacterial 16S rRNA gene.

Authors:  M M Tunney; S Patrick; M D Curran; G Ramage; D Hanna; J R Nixon; S P Gorman; R I Davis; N Anderson
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

7.  Chronic osteomyelitis. The effect of the extent of surgical resection on infection-free survival.

Authors:  A H Simpson; M Deakin; J M Latham
Journal:  J Bone Joint Surg Br       Date:  2001-04

8.  Further observations on the value of oral penicillins in chronic staphylococcal osteomyelitis.

Authors:  S M Bell
Journal:  Med J Aust       Date:  1976-10-16       Impact factor: 7.738

9.  The white blood cell scan in orthopedics.

Authors:  S L Propst-Proctor; M F Dillingham; I R McDougall; D Goodwin
Journal:  Clin Orthop Relat Res       Date:  1982-08       Impact factor: 4.176

10.  The production of prostaglandins in response to experimentally induced osteomyelitis in rabbits.

Authors:  M Corbett; S Dekel; B Puddle; R A Dickson; M J Francis
Journal:  Prostaglandins Med       Date:  1979-06
View more
  7 in total

1.  Testing of antibiotic releasing implant coatings to fight bacteria in combat-associated osteomyelitis - an in-vitro study.

Authors:  David Alexander Back; Nicole Bormann; Arash Calafi; Julie Zech; Leif Alexander Garbe; Martin Müller; Christian Willy; Gerhard Schmidmaier; Britt Wildemann
Journal:  Int Orthop       Date:  2016-02-23       Impact factor: 3.075

2.  Systemic antimicrobial therapy in osteomyelitis.

Authors:  Henry S Fraimow
Journal:  Semin Plast Surg       Date:  2009-05       Impact factor: 2.314

3.  Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis.

Authors:  Naïm Bouazza; Vincent Pestre; Vincent Jullien; Emmanuel Curis; Saïk Urien; Dominique Salmon; Jean-Marc Tréluyer
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

4.  Musculoskeletal infection imaging: past, present, and future.

Authors:  Santiago Restrepo; Daniel Vargas; Roy Riascos; Hugo Cuellar
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.725

5.  Phage therapy of staphylococcal chronic osteomyelitis in experimental animal model.

Authors:  Chandan Kishor; Raghvendra Raman Mishra; Shyam K Saraf; Mohan Kumar; Arvind K Srivastav; Gopal Nath
Journal:  Indian J Med Res       Date:  2016-01       Impact factor: 2.375

6.  Decorin reduces hypertrophic scarring through inhibition of the TGF-β1/Smad signaling pathway in a rat osteomyelitis model.

Authors:  Peng Wang; Xiangyan Liu; Peng Xu; Jialiang Lu; Runze Wang; Weidong Mu
Journal:  Exp Ther Med       Date:  2016-08-12       Impact factor: 2.447

7.  Combining in vitro protein detection and in vivo antibody detection identifies potential vaccine targets against Staphylococcus aureus during osteomyelitis.

Authors:  P Martijn den Reijer; Marjan Sandker; Susan V Snijders; Mehri Tavakol; Antoni P A Hendrickx; Willem J B van Wamel
Journal:  Med Microbiol Immunol       Date:  2016-09-14       Impact factor: 3.402

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.